scGRNom: a computational pipeline of integrative multi-omics analyses for predicting cell-type disease genes and regulatory networks
Year: 2021
Type: article
Abstract: Understanding cell-type-specific gene regulatory mechanisms from genetic variants to diseases remains challenging. To address this, we developed a computational pipeline, scGRNom (single-cell Gene Regulatory Network prediction from multi-omics), to predict cell-type disease genes and regulatory networks including transcription factors and regulatory elements. With applications to schizophrenia and Alzheimer's disease, we predicted disease genes and regulatory networks for excitatory and inhibitory neurons, microglia, and oligodendrocytes. Further enrichment analyses revealed cross-disease and disease-specific functions and pathways at the cell-type level. Our machine learning analysis also found that cell-type disease genes improved clinical phenotype predictions. scGRNom is a general-purpose tool available at https://github.com/daifengwanglab/scGRNom .
Source: Genome Medicine
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $4,480
Awards: 1/2 Discovery and validation of neuronal enhancers associated with the development of psychiatric disorders, Waisman Intellectual and Developmental Disabilities Research Center, A new bladder cancer model based on tissue reprogramming and gene targeting, Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease, G5741685586, G696844456
OpenAlex ID: W3164212224
